The earnings results for IDEXX Laboratories (NASDAQ:IDXX) for Q4 were made public on Monday, February 2, 2026 at 06:30 AM.

Here's a comprehensive overview of the announcement.

Earnings

IDEXX Laboratories beat estimated earnings by 5.0%, reporting an EPS of $3.08 versus an estimate of $2.93.

Revenue was up $136.71 million from the same period last year.

Previous Earnings Records

During the previous quarter, the company beat on EPS by $0.08, leading to a 0.0% increase share price change the next day.

Here's a look at IDEXX Laboratories's past performance:

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Guidance

IDEXX Laboratories management provided guidance for FY 2026, expecting earnings between $14.29 and $14.8 per share.

To track all earnings releases for IDEXX Laboratories visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.